Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
82.65
+0.91 (1.11%)
Market open: Aug 12, 2026, 11:11 AM EDT
80.11
-1.63 (-1.99%)
Previous after-hours: Aug 11, 2026, 7:58 PM EDT
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
| Name | Position |
|---|---|
| Dr. Bryan M. Dechairo Ph.D. | Chief Technology & Innovation Officer |
| Mr. Kevin Feeley CPA | Chief Financial Officer |
| Mr. Mark A. Gardner M.B.A. | President |
| Ms. Heidi C. Chen J.D. | Chief Legal Officer |
| Ms. Jami Biliboaca | Chief People Officer |
| Ms. Katherine A. Stueland | CEO & Director |
| Ms. Linda Genen M.D., M.P.H. | Chief Medical Officer |
| Ms. Lisa Gurry | Chief Business Officer |
| Ms. Melanie Duquette | Chief Growth Officer |
| Ms. Sabrina V. Dunbar | Director of Investor Relations & Communications |
| Date | Type | Document |
|---|---|---|
| 2026-08-03 | 10-Q | wgs-20260630.htm |
| 2026-06-23 | 8-K | wgs-20260618.htm |
| 2026-06-16 | 8-K | wgs-20260615.htm |
| 2026-05-04 | 8-K | wgs-20260504.htm |
| 2026-05-04 | 10-Q | wgs-20260331.htm |
| 2026-04-30 | DEF 14A | wgs-20260430.htm |
| 2026-03-02 | 8-K | wgs-20260227.htm |
| 2026-02-23 | S-8 | s-82026evergreen.htm |
| 2026-02-23 | 8-K | wgs-20260223.htm |
| 2026-01-12 | 8-K | wgs-20260112.htm |